Robard Launches 'Biocare2' to Address Nutritional Needs Post-GLP-1 Treatment

Medically guided nutrition specialist Robard has announced the launch of Biocare2, a specialised dietary beverage engineered to support individuals transitioning off GLP-1 weight management medications.

The product release addresses a growing "maintenance gap" in the weight loss sector. As patient usage of GLP-1 agonists evolves, a new challenge has emerged regarding the management of returning appetite and the preservation of lean muscle mass once treatment concludes or tapers off.

Formulation and Metabolic Support

Biocare2 is designed using an evidence-informed approach to promote satiety and metabolic health during this critical transition phase. The formulation prioritises high-protein and fibre density to counteract the physiological rebound often experienced post-treatment.

Key Nutritional Specifications (Per Serving):

Protein: 30 grams of high-quality protein to support muscle maintenance.
Fibre: 9 to 11 grams (depending on flavour) to aid satiety and digestive health.
Micronutrients: Fortified with 26 essential vitamins and minerals.
Functional Additives: Includes probiotics for gut health and creatine to support energy utilisation and lean mass preservation.

A 'Stage-Based' Approach

With this launch, Robard is defining a clear, stage-based nutrition strategy for the medical weight loss market. The company now segments its portfolio to address specific phases of the patient journey:

Biocare: Formulated for active GLP-1 use, focusing on mitigating side effects like digestive discomfort and nutritional intake during appetite suppression.
Biocare2: Formulated for the transition and long-term phase, focusing on appetite control and muscle retention as the body readjusts.

Mario Testa, Vice President of Sales at Robard, explained the product's role in the evolving treatment landscape:

"Biocare2 was created in response to what we're seeing in real-world use of GLP-1 medications. While our original Biocare product is formulated to support individuals during active GLP-1 use—particularly around nutrition and digestive comfort—Biocare2 is designed to support the transition and long-term phase, when appetite returns and sustaining results becomes the priority."

Commercial Availability

Biocare2 is manufactured in FDA-registered facilities in the United States. The product line launches with four flavour variants designed for daily compliance: